Brinton Pharmaceuticalson Monday said it is planning to export antiviral drugFavipiravir to Gulf countries and will launch it in India after getting approval from theDrugs Controller General of India(DCGI).
Favipiravir is a generic version of Avigan of Fujifilm Toyama Chemical Co Ltd, Japan, a subsidiary of Fujifilm Corporation,Brinton Pharmaceuticals said in a statement.
The drug will be marketed by the company under the brand name 'Faviton'and will be available in 200mg and 400mg tablets, itadded.
"The company will besupplying the drug to the Gulf region countries and will launch it in India after getting approval from DCGI,"Brinton PharmaceuticalsChairman and MDRahul Kumar Darda said.
Recently, the Task Force for Repurposing of Drugs for COVID-19 formed by the government, has classified Favipiravir and Tocilizumab as the drugs that have shown maximum readiness and potential in the fight against the disease, he added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
